P-257 Detection of early lung cancer in high risk population: Aprospective study

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S182
Author(s):  
B. Lam ◽  
C. Tam ◽  
S. Lam ◽  
M. Wong ◽  
C. Ooi ◽  
...  
2013 ◽  
Vol 82 (1) ◽  
pp. 25-31 ◽  
Author(s):  
Agata Zakrzewska ◽  
Magdalena Szczepanowska ◽  
Janina Książek ◽  
Iwona Biadacz ◽  
Robert Dziedzic ◽  
...  

Lung Cancer ◽  
2020 ◽  
Vol 148 ◽  
pp. 79-85
Author(s):  
Mark R. Waddle ◽  
Stephen J. Ko ◽  
Jackson May ◽  
Tasneem Kaleem ◽  
Daniel H. Miller ◽  
...  

1975 ◽  
Vol 84 (5) ◽  
pp. 583-588 ◽  
Author(s):  
David R. Sanderson ◽  
Robert S. Fontana

The Mayo Lung Project was established to develop and evaluate a screening program for early lung cancer in high-risk subjects. Men who are more than 45 years of age and who smoke one package of cigarettes or more daily are screened by the use of thoracic roentgenograms, three-day pooled sputum cytology, and lung health questionnaires at four-month intervals. These data are compared with data from similar subjects screened only on entry into the project. During the past three years, 34 patients who had no roentgenographic evidence of lung cancer were identified and examined because of carcinoma cells in sputum. Of these 34 patients, 27 have had bronchoscopic localization of their tumors and definitive treatment, and 3 had upper respiratory tract neoplasms and also have been treated. Of the remaining four, one patient died suddenly after myocardial infarction and three patients have not had localization or treatment because of other severe complicating medical problems. Localization of roentgenographically occult lung cancer is reliable by the use of bronchofiberoscopy and meticulous, thorough sampling from the tracheobronchial tree. A search must be made for upper airway cancers in the same high-risk population, and the possibility of second primary bronchogenic tumors also must be considered. Although follow-up is short, 22 of the 27 treated lung cancer patients were found with stage I disease. The outlook for 19 of these 27 is encouraging an average of 16 months after surgical resection.


2014 ◽  
Vol 9 (6) ◽  
pp. 752-759 ◽  
Author(s):  
Alicia Hulbert ◽  
Craig M. Hooker ◽  
Jeanne C. Keruly ◽  
Travis Brown ◽  
Karen Horton ◽  
...  

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 6507-6507
Author(s):  
Derek Raghavan ◽  
Darcy L. Doege ◽  
Mellisa S Wheeler ◽  
Kia Dungan ◽  
Lauren Davis ◽  
...  

6507 Background: Randomized trials have proven that screening high-risk patients with LDCT of chest reduces lung cancer mortality compared to screening with chest x-ray. Under-served patients lack access to this test due to geographic and socio-economic factors. We hypothesized that a mobile screening unit would improve access and increase survival in this group, which is most at risk of lung cancer deaths. Methods: We installed a BodyTom portable 32 slice low-dose CT scanner (Samsung Inc) into a 35 foot coach (Frazier Inc), reinforced to avoid equipment damage during road travel. It includes waiting area, high speed wireless internet connection for rapid image transfer, and electronic tablets to deliver smoking cessation and health education programs and shared decision-making video aids. We used LUNG RADS approach to lesion classification, yielding high sensitivity and specificity in assessment. All films were reviewed by a central panel. This is certified as a lung cancer screening Center of Excellence by the Lung Cancer Alliance. Protocol was approved by Advarra IRB. Medicare pts excluded as insurance covered them for LDCT, although this reduced potential number of cases diagnosed as this is highest risk population. Results: We screened 1200 uninsured or under-insured subjects, mean age 61 years (range 55-64), with average pack year history of 47.8 (30-150); 61% male; 18% Black, 3% Hispanic/Latino; 78% rural. We found 97 pts with LUNG RADS 4 lesions, 30 lung cancers (2.5%), including 15 at stage I-II treated with curative intent; 5 incidental non-lung cancers (renal CA 2, head & neck CA 1, pancreas CA 2); more than 50% with cardiovascular disease or COPD seen on LDCT. Of eligible first-screen subjects (J. Clin. Oncol., 2019, 37, 383S), 440 attended Year 1 repeat LDCT and 161 attended Year 2 LDCT. Only one pt with surgically resected CA lung has relapsed to date. Conclusions: Mobile LDCT yields higher screening rate for under-served pts than prior international studies, with strong protocol adherence and paucity of early cancer deaths in high-risk population with traditionally poor compliance.


PLoS ONE ◽  
2016 ◽  
Vol 11 (11) ◽  
pp. e0165471 ◽  
Author(s):  
C. Matthew Kinsey ◽  
Katharine L. Hamlington ◽  
Jacqueline O’Toole ◽  
Renee Stapleton ◽  
Jason H. T. Bates

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S184
Author(s):  
S. Novelle ◽  
C. Fava ◽  
P. Lausi ◽  
L. Cardinale ◽  
M. Brizzi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document